England’s successful diabetes prevention program as blueprint for Canada
Canada can learn from England's diabetes prevention program to build its own initiatives to combat rising rates...
New blood test aims to detect aggressive prostate cancer earlier
By identifying cancer-specific methylation signals in blood, researchers hope to enable safer, earlier detection of high-risk prostate cancer
The Institute’s Clinical Observership Program: Bridging lab research and patient care
Four postdoctoral trainees take part in a new initiative that deepens their understanding of the diseases...
Better breathing, better treatment for COPD
New research from researchers at The Institute finds that nearly a third of patients with COPD are at risk of using inhalers ill-suited to their breathing...
Team from The Institute selected for XPRIZE Healthspan award
Gustavo Duque and the Canadian Translational Geroscience Network awarded $250,000 and selected to advance in the $101 million competition
Researchers uncover novel immune mechanism that protects the intestine
By studying intestinal worms, scientists from The Institute make a breakthrough in gut immunity—opening the door...
First patients in Canada enrolled in global radioligand therapy trial for metastatic cancer
One year after becoming the first centre in Canada to open a clinical trial of a radioligand therapy for metastatic...
Future of HIV Diagnostics: Experts chart a path forward
A new review in The Lancet HIV, co-authored by Dr. Nitika Pant Pai, highlights innovative tools—from AI to quantum diagnostics—poised to...
Awards for Equity, Diversity and Inclusion in health care research
The Institute celebrates academic excellence of medical and health science students from equity seeking groups
Vaping cannabis could harm your lungs
Two recent studies from The Institute suggest that cannabis vapour may have adverse effects on lung cells.